Generic name:satralizumab [ SAT-ra-LIZ-ue-mab ]
Drug class:Interleukin inhibitors
What is Enspryng?
Enspryng is a recombinant humanized monoclonal antibody targeting human interleukin-6 (IL-6) receptors.
Enspryng is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD). NMOSD is a rare, chronic autoimmune disease that causes inflammation in the central nervous system. This can lead to damage of the optic nerves, spinal cord, and/or brain.
Enspryng is used only if your body produces antibodies to a protein called aquaporin-4 (AQP4). Your doctor will test you for this antibody.
Warnings
Enspryng affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have signs of infection (fever, chills, cough, tiredness, muscle pain, diarrhea, stomach cramps, increased urination, burning when you urinate, skin sores or redness, swelling or tenderness).
Your healthcare provider will check if you have an infection and treat it if needed before you start or continue to take Enspryng.
Your healthcare provider should test you for hepatitis and tuberculosis (TB) before you start taking Enspryng.
Before taking this medicine
You should not use Enspryng if you are allergic to satralizumab, or if you have an active infection such as:
hepatitis B; or
To make sure Enspryng is safe for you, tell your doctor if you have ever had: tuberculosis, if anyone in your household has tuberculosis, or if you have recently traveled to an area where tuberculosis is common.
To make sure Enspryng is safe for you, tell your doctor if you have ever had:...
